TABLE 2.
Gene | No. of patients included in the analysis | Responding | Not responding | |
---|---|---|---|---|
Objective description | Subjective description | |||
PDSS1 | 0 | – | – | – |
PDSS2 | 2 | 0 | 0 | 2 |
COQ2 | 7 | 1 | 0 | 6 |
COQ4 | 19 | 3 | 2 | 14 |
COQ5 | 3 | 3 | 0 | 0 |
COQ6 | 3 | 1 | 0 | 2 |
COQ7 | 3 | 0 | 0 | 3 |
COQ8A/ADCK3 | 41 | 9 | 2 | 30 |
COQ8B/ADCK4 | 9 | 3 | 0 | 6 |
COQ9 | 2 | 0 | 0 | 2 |
Note: Treatment effects established by quantitative or semi‐quantitative measures to describe the response to CoQ10 treatment were counted as responding with objective description, while descriptions of positive effects but without relying on quantitative or semi‐quantitative measures were counted as responding with subjective description. ‘Not responding’ include the patients who were reported not to respond to CoQ10 treatment or whose responses we consider lacking a convincing demonstration of a response to CoQ10 supplementation.